ES - Eisai & Pfizer v. Mylan / Donepezil / Interim Injunction

Eisai Co. Ltd. & Pfizer S.A. v. Mylan Pharmaceuticals S.L., Commercial Court No. 5 of Barcelona, Spain, 29 December 2009, Docket No. 581/2009

Commercial Court No. 5 of Barcelona has confirmed its previous decision of 29 July 2009 pursuant to which it granted interim injunction inaudita parte against Mylan Pharmaceuticals (Mylan), which had been ordered to temporarily refrain from commercializing in Spain generic drugs with the active compound donepezil for the treatment of mild to moderate dementia caused by Alzheimer's disease.